Madison Investment Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History

Madison Investment Advisors’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	$4.59M	Buy	+6,445	New	+$5.41M	0.05%	173

Other funds holding REGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Madison Investment Advisors's REGN Position: Q4 2024 in Review

Madison Investment Advisors opened a new position in Regeneron Pharmaceuticals (REGN) in Q4 2024: 6,445 shares worth $4.59M. The stake represents 0.05% of the portfolio and ranks #173 among its holdings.

1,320 funds tracked by Wall St. Rank hold REGN as of Q4 2024.

Madison Investment Advisors held 6,445 shares of Regeneron Pharmaceuticals worth $4.59M as of Q4 2024.
Regeneron Pharmaceuticals was a new Madison Investment Advisors position in Q4 2024.
Regeneron Pharmaceuticals made up 0.05% of Madison Investment Advisors's portfolio in Q4 2024, its #173 holding.
1,320 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2024.

Based on Madison Investment Advisors's 13F filing for Q4 2024, filed 10 Feb 2025.